SURUFATINIB
Clinical trials for SURUFATINIB explained in plain language.
Never miss a new study
Get alerted when new SURUFATINIB trials appear
Sign up with your email to follow new studies for SURUFATINIB, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for inoperable esophageal cancer: Triple-Threat treatment trial
Disease control Recruiting nowThis study is testing a new combination treatment for people with advanced esophageal cancer that cannot be removed by surgery. The treatment involves a targeted drug (surufatinib), immunotherapy (toripalimab), chemotherapy, and radiation. The goal is to see if this combination c…
Matched conditions: SURUFATINIB
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Apr 03, 2026 14:43 UTC
-
Four-Pronged attack on aggressive lung cancer enters human testing
Disease control Recruiting nowThis study is testing a new combination treatment for people with limited-stage small cell lung cancer, a fast-growing type of lung cancer. The treatment combines standard chemotherapy and radiation with two newer drugs: toripalimab (an immunotherapy) and surufatinib (a targeted …
Matched conditions: SURUFATINIB
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Apr 02, 2026 14:57 UTC